| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000080 | Mitotic g1 phase | Increases phenotype | PMID:31332466 |
| GO:0000084 | Mitotic s phase | Decreases phenotype | PMID:31332466 |
| GO:0001655 | Urogenital system development | Affects phenotype | PMID:32416200 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:24132472 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:29702088 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:25223798; PMID:28858478 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:25048947 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:27718046 |
| GO:0006754 | Atp biosynthetic process | Affects phenotype | PMID:28301301; PMID:35435491 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:24395120; PMID:31332466; PMID:25371527; PMID:25371527; PMID:26215658; PMID:26215658; PMID:31332466 |
| GO:0006882 | Cellular zinc ion homeostasis | Decreases phenotype | PMID:28919410 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:24132472; PMID:25146423; PMID:27592553; PMID:28301301; PMID:31332466 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:25146423; PMID:27633978 |
| GO:0007010 | Cytoskeleton organization | Affects phenotype | PMID:27633978; PMID:35230478 |
| GO:0007049 | Cell cycle | Affects phenotype | PMID:27633978 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:35230478 |
| GO:0007613 | Memory | Decreases phenotype | PMID:28564613 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:26988606 |
| GO:0008219 | Cell death | Increases phenotype | PMID:24395120; PMID:26640238; PMID:27592553; PMID:27718046; PMID:28851516 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:24395120; PMID:27592553; PMID:27718046; PMID:28616630; PMID:28811233; PMID:29653259; PMID:33095664 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:26979758; PMID:26988606 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30098271; PMID:30766661; PMID:30951941; PMID:32763284; PMID:35734227; PMID:35734227 |
| GO:0010001 | Glial cell differentiation | Increases phenotype | PMID:28851516 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:38995820 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:27998958 |
| GO:0010826 | Negative regulation of centrosome duplication | Decreases phenotype | PMID:27998958 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:25777084 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:30951941; PMID:39586487 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:28919410 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25223798; PMID:26718265 |
| GO:0016042 | Lipid catabolic process | Affects phenotype | PMID:29702088 |
| GO:0016477 | Cell migration | Decreases phenotype | PMID:33969458 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:25863188 |
| GO:0022008 | Neurogenesis | Decreases phenotype | PMID:28564613 |
| GO:0030033 | Microvillus assembly | Increases phenotype | PMID:32041402 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:28851516; PMID:33969458 |
| GO:0030954 | Astral microtubule nucleation | Increases phenotype | PMID:27998958 |
| GO:0031116 | Positive regulation of microtubule polymerization | Increases phenotype | PMID:27998958 |
| GO:0031175 | Neuron projection development | Decreases phenotype | PMID:31332466 |
| GO:0032048 | Cardiolipin metabolic process | Affects phenotype | PMID:28301301 |
| GO:0032148 | Activation of protein kinase b activity | Increases phenotype | PMID:30766661 |
| GO:0032308 | Positive regulation of prostaglandin secretion | Increases phenotype | PMID:30055667 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:25449125; PMID:26979758 |
| GO:0033864 | Positive regulation of nad(p)h oxidase activity | Increases phenotype | PMID:30766661 |
| GO:0034389 | Lipid droplet organization | Increases phenotype | PMID:28329833 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:30098271; PMID:30951941 |
| GO:0034454 | Microtubule anchoring at centrosome | Increases phenotype | PMID:27998958 |
| GO:0042310 | Vasoconstriction | Increases phenotype | PMID:35321852 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:28301301 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:30951941 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:39586487 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:26215658; PMID:27093678; PMID:32041402; PMID:33969458 |
| GO:0044255 | Cellular lipid metabolic process | Affects phenotype | PMID:34323617 |
| GO:0045019 | Negative regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:38369087 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:25863188; PMID:30496566; PMID:32473317 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:25777084 |
| GO:0045669 | Positive regulation of osteoblast differentiation | Decreases phenotype | PMID:25777084 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:30766661 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Affects phenotype | PMID:31332466 |
| GO:0046460 | Neutral lipid biosynthetic process | Increases phenotype | PMID:35734227 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:28564613 |
| GO:0048709 | Oligodendrocyte differentiation | Decreases phenotype | PMID:33969458 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Affects phenotype | PMID:33078840 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:30766661 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:38995820 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:31750923 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:27718046 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:31404653 |
| GO:0051899 | Membrane depolarization | Increases phenotype | PMID:28143888 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:27718046; PMID:28143888; PMID:28858478 |
| GO:0060009 | Sertoli cell development | Decreases phenotype | PMID:35230478 |
| GO:0060548 | Negative regulation of cell death | Increases phenotype | PMID:37487893 |
| GO:0061089 | Negative regulation of sequestering of zinc ion | Increases phenotype | PMID:28919410 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:25146423; PMID:25576683 |
| GO:0061900 | Glial cell activation | Increases phenotype | PMID:28564613 |
| GO:0070509 | Calcium ion import | Increases phenotype | PMID:26215658 |
| GO:0071577 | Zinc ion transmembrane transport | Increases phenotype | PMID:28919410 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:35230478 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:28301301 |
| GO:0110053 | Regulation of actin filament organization | Affects phenotype | PMID:31750923 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:25048947 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:30766661 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:28919410 |
| GO:1901612 | Cardiolipin binding | Affects phenotype | PMID:28301301 |
| GO:1903353 | Regulation of nucleus organization | Affects phenotype | PMID:31750923 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:24395120; PMID:24395120; PMID:31332466; PMID:27592553; PMID:27718046; PMID:31332466 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28919410; PMID:30098271; PMID:30766661; PMID:30951941; PMID:35950316 |
| GO:1904181 | Positive regulation of membrane depolarization | Increases phenotype | PMID:30769291 |
| GO:1904251 | Regulation of bile acid metabolic process | Affects phenotype | PMID:33078840 |
| GO:1905665 | Positive regulation of calcium ion import across plasma membrane | Increases phenotype | PMID:28919410 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:31332466 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:25576683 |
| GO:2000278 | Regulation of dna biosynthetic process | Affects phenotype | PMID:31750923 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:24278553 |
| GO:2000611 | Positive regulation of thyroid hormone generation | Decreases phenotype | PMID:26988606 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:25576683; PMID:30055667 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:30055667 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:25223798 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:30055667 |
| GO:2001025 | Positive regulation of response to drug | Increases phenotype | PMID:35734227 |
| GO:2001057 | Reactive nitrogen species metabolic process | Affects phenotype | PMID:28301301 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.